European Archives - Page 649 of 1125 - European Medical Journal

Smartwatch Tracks Medication Levels in Sweat

WEARABLE technologies may further personalise medical care, as a custom smartwatch has been developed to track medication levels from sweat in real time. …

Retinal Deterioration Mapped by Artificial Intelligence

AUTOMATED measurement of atrophic lesions in geographic atrophy has been developed through the use of artificial intelligence (AI). The software…

Prediction Tool Assesses Newborn Risk of Type 1 Diabetes Mellitus Development

THE ENVIRONMENTAL Determinants of Diabetes in the Young (TEDDY) study data have shown that multiple factors influence whether a child will go on to…

High Blood Sugar May Trigger Worse Outcomes in Patients with SARS-CoV-2

SEVERE hyperglycaemia and comorbid infection with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has been studied in 200 patients by a…

Management of Atrial Fibrillation (AF) with ACS and/or Undergoing PCI

Interventional cardiologist Dr Amit N. Vora discusses patients with both Atrial Fibrillation (AF) and Acute Coronary Syndrome (ACS), and whether they…

Talking to Dario Safaric

Dario Safaric, Chairman of the NEXT Pharma Summit, shares his journey of starting a conference from scratch, Croatia’s historical relationship with the pharmaceutical industry, and the future outlook for medical conferences in the post-COVID-19 era.

Differential Diagnosis of Nail Psoriasis and Onychomycoses: A Report Based on 40 Years of Specialised Nail Consultations

Ungual psoriasis and onychomycosis are common nail diseases. Despite their different aetiology and course, surprisingly they have much in common.

Charcot–Marie–Tooth Mutation May Prompt Novel Gene Therapy

DYSTONIN, a gene that maintains nerve cells, is now known to undergo inherited mutations that lead to a neuropathy known as Charcot–Marie–Tooth disease…

Should We Target Obesity to Avoid Alzheimer’s?

OBESITY has been linked to brain dysfunction in a large new study measuring cerebral blood flow, the primary predictor that an individual may develop Alzheimer’s disease.

EMJ Podcast: Risk-takers and Rulebreakers

This week, Jonathan Sackier chats to Dr. Dan Mahony, Co-Head Healthcare, Polar Capital. Listen now to find out more